LRBA deficiency is associated with autoimmune disease and CTLA4 loss; this study identifies LRBA as a negative regulator of antitumor immunity and introduces LC427 as a promising small-molecule ...
This scheme has consistently delivered the best returns in its Small-Cap category across . This scheme has maintained a relatively low level of volatility within its Small-Cap category over the past 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback